CRIF1 Anti-Cancer and Anti-Metastasis Composition Comprising CRIF1 Antagonist

摘要

The present invention relates to a composition effective in inhibiting cancer and metastasis by inhibiting cell migration, and more particularly, to a pharmaceutical composition for inhibiting cancer and metastasis comprising a CR6 interacting factor 1 (CRIF1) gene expression inhibitor or a CRIF1 protein activity inhibitor as an active ingredient.